Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Analyst Ratings for Veracyte

Within the last quarter, Veracyte (NASDAQ:VCYT) has observed the following analyst ratings:

Benzinga

A Preview Of INmune Bio's Earnings

INmune Bio (NASDAQ:INMB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that INmune Bio will report an earnings per share (EPS) of $-0.64.

Benzinga

What's Going On With Plug Power Shares Today?

Shares of several companies in the broader industrials sector, including Plug Power Inc (NASDAQ: PLUG), are trading higher amid overall market strength after the Federal Reserve announced it would raise the key interest rate by 50 basis points.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Lyft Analysts React To Q2 Guidance Miss, Heavy Investments In Lagging Driver Recovery

LYFT Inc (NASDAQ: LYFT) shares plummeted 32% on Wednesday after the company issued second-quarter guidance that came up well short of market expectations.

Benzinga

What's Going On With Apple Shares Today?

Shares of several companies in the broader tech sector, including Apple Inc (NASDAQ: AAPL), are trading higher amid overall market strength after the Federal Reserve announced it would raise the key interest rate by 50 basis points.

Benzinga

Oatly Group Reports Mixed Q1 Earnings; Reiterates FY22 Outlook

Oatly Group AB (NASDAQ:OTLY) reported first-quarter FY22 sales growth of 18.6% year-on-year to $166.19 million, beating the consensus of $161.78 million. Revenue in the Americas jumped 40.3% Y/Y to $47 million, EMEA rose 10.9% to $90.5 million, and Asia grew 15.3% to $28.7 million. Gross margin contracted by 2,040 basis points to 9.5%,…

Benzinga

Mid-Afternoon Market Update: Crude Oil Jumps 5%; Fed Boosts Interest Rates By 0.5%

U.S. stocks traded mixed toward the end of trading, after the Federal Reserve announced its policy decision.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

ODP Q1 Earnings Beat Estimates Despite Fewer Retail Stores

ODP Corp (NASDAQ:ODP) reported a first-quarter FY22 sales of $2.18 billion, flat Y/Y, beating the consensus of $2.13 billion. Business Solutions Division sales climbed 9% Y/Y, while Retail division sales decreased 9%. Adjusted EPS of $1.27 beat the analyst consensus of $0.79. Gross profit declined 2.2% Y/Y to $484 million with a margin…

Benzinga

A Preview Of Oncolytics Biotech's Earnings

Oncolytics Biotech (NASDAQ:ONCY) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Oncolytics Biotech will report an earnings per share (EPS) of $-0.11.

Benzinga

Preview: Corcept Therapeutics's Earnings

Corcept Therapeutics (NASDAQ:CORT) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Corcept Therapeutics will report an earnings per share (EPS) of $0.24.

Benzinga

A Preview Of Mirum Pharmaceuticals's Earnings

Mirum Pharmaceuticals (NASDAQ:MIRM) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Mirum Pharmaceuticals will report an earnings per share (EPS) of $-1.34.

Benzinga

Earnings Outlook For Selecta Biosciences

Selecta Biosciences (NASDAQ:SELB) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Selecta Biosciences will report an earnings per share (EPS) of $-0.11.

Benzinga

Akoya Biosciences Earnings Preview

Akoya Biosciences (NASDAQ:AKYA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Akoya Biosciences will report an earnings per share (EPS) of $-0.39.

Benzinga

Check Out What Whales Are Doing With BYND

Someone with a lot of money to spend has taken a bearish stance on Beyond Meat (NASDAQ:BYND). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Twist Bioscience's Earnings: A Preview

Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Twist Bioscience will report an earnings per share (EPS) of $-1.28.

Benzinga

What 4 Analyst Ratings Have To Say About Paramount Global

Analysts have provided the following ratings for Paramount Global (NASDAQ:PARA) within the last quarter:

Benzinga

AMD, Micron Or Nvidia: Which Chip Stock Did This Investor Just Dump And Why?

Steve Weiss cut Micron Technology Inc (NASDAQ: MU) from his portfolio on Wednesday, citing concerns that he suggested could be plaguing the entire semiconductor industry.

Benzinga

Earnings Outlook For Franchise Group

Franchise Group (NASDAQ:FRG) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Franchise Group will report an earnings per share (EPS) of $1.09.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Is What Whales Are Betting On Fortinet

Someone with a lot of money to spend has taken a bearish stance on Fortinet (NASDAQ:FTNT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Analyst Ratings for Expeditors International

Expeditors International (NASDAQ:EXPD) has observed the following analyst ratings within the last quarter:

Benzinga

What Are Whales Doing With Cassava Sciences

Someone with a lot of money to spend has taken a bullish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

How Is The Market Feeling About Prospect Capital?

Prospect Capital's (NASDAQ:PSEC) short percent of float has risen 9.4% since its last report. The company recently reported that it has 4.60 million shares sold short, which is 1.63% of all regular shares that are available for trading.

Benzinga

6 Analysts Have This to Say About Macrogenics

Macrogenics (NASDAQ:MGNX) has observed the following analyst ratings within the last quarter:

Benzinga

4 Stocks Moved By Traders on 'Fast Money: Halftime Report'

CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.

Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday.

1 … 488 489 490 491

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.